Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

From ancient times until now, scientists have focused on herbal medicaments for treating various diseases. Rottlerin, a potent PKCδ inhibitor, is one of the greatest herbal medications. Over the years, it was identified that rottlerin has several cellular and molecular targets that could be involved in the fight against cancer. The past and present research has clearly shown that rottlerin inhibits the transcription factors, enzymes, and signaling molecules that regulate the death and life of cancer cells. Although the anticancer property of rottlerin has primarily been attributed to the induction of autophagy and apoptosis, current research has revealed the existence of different damage pathways. The major part described in this mini-review is the antitumor/anticancer effects of rottlerin in various organs of the human body affected by breast cancer, pancreatic cell cancer, bladder cancer, NSCLC, prostate cancer, ovarian cancer, nasopharyngeal cancer, etc.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947244863230928095352
2024-05-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/0115733947244863230928095352
Loading

  • Article Type:
    Review Article
Keyword(s): anti-cancer; anti-viral; antiangiogenic; mTOR signaling; PKCδ inhibitor; Rottlerin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test